Click Here for 5% Off Your First Aladdin Purchase!

Levilimab (anti-IL-6Ra) - Primary antibody, specific to IL6R, >95% (SDS-PAGE&SEC), high purity, Human IgG1, INHIBITOR of Interleukin-6 receptor alpha subunit inhibitor

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Human
  • Isotype: Human IgG1
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab182913
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab182913-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$109.90
Ab182913-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$519.90
Ab182913-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,399.90
Ab182913-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,239.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameLevilimab (anti-IL-6Ra) - Primary antibody, specific to IL6R, >95% (SDS-PAGE&SEC), high purity, Human IgG1
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityIL6R
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionINHIBITOR of Interleukin-6 receptor alpha subunit inhibitor
Product Description

Levilimab (anti-IL-6Ra) is a fully human anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab (anti-IL-6Ra) is an inflammation-alleviating antibody. Levilimab (anti-IL-6Ra) can be used for the research of rheumatoid.

Purity

>95% (SDS-PAGE&SEC)

Endotoxin Level

< 1.0EU/mg

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE28.0 kDa (Light Chain) & 55.0 kDa (Heavy Chain), under reducing conditions; 217.8 kDa, under non-reducing conditions.
Purification MethodProtein A purified
Purity>95% (SDS-PAGE&SEC)
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS2035008-70-7

Images

Levilimab (anti-IL-6Ra) (Ab182913) - ELISA
Immobilized Recombinant Human IL-6Ra protein (rp181252) at 1.0 μg/mL can bind Levilimab (anti-IL-6Ra) (Ab182913) with the EC50 of 78.97 ng/mL.

Levilimab (anti-IL-6Ra) (Ab182913) - SEC
The purity of Levilimab (anti-IL-6Ra) (Ab182913) is more than 95% verified by HPLC.

Associated Targets

IL6R Tclin Interleukin-6 receptor subunit alpha 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0708127Certificate of AnalysisJul 11, 2024 Ab182913
ZJ24F0708126Certificate of AnalysisJul 11, 2024 Ab182913
ZJ24F0708125Certificate of AnalysisJul 11, 2024 Ab182913

Related Documents

Solution Calculators